Majed Alokail received his BSc and MSc in Biochemistry from King Saud University in Riyadh, Saudi Arabia. He attained a high diploma in Insulin Gene Therapy from Gunma University, Maebashi, Japan, and his PhD in Molecular Pharmacology from the University of Southampton, UK. Currently, he is a Protein Research Chair at the Department of Biochemistry, College of Science, King Saud University. He is also a member of the British Biochemical Society, Middle East Association of Cancer Research, and Federation of American Societies for Experimental Biology. His research interests include Cancer Molecular Biology, Cancer Epigenetics, Molecular Pharmacology, Apoptosis and Molecular Signaling, and Molecular Endocrinology.
Majed Alokail received his BSc and MSc in Biochemistry from King Saud University in Riyadh, Saudi Arabia. He attained a high diploma in Insulin Gene Therapy from Gunma University, Maebashi, Japan, and his PhD in Molecular Pharmacology from the University of Southampton, UK. Currently, he is a Protein Research Chair at the Department of Biochemistry, College of Science, King Saud University. He is also a member of the British Biochemical Society, Middle East Association of Cancer Research, and Federation of American Societies for Experimental Biology. His research interests include Cancer Molecular Biology, Cancer Epigenetics, Molecular Pharmacology, Apoptosis and Molecular Signaling, and Molecular Endocrinology.